Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AZN compared with BSX: revenue, margins and what each company keeps, and the suppliers and customers both name
AZN
Astrazeneca PLC
Change
Mkt cap
Revenue
Revenue
BSX
Boston Scientific Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
AZN
Astrazeneca PLC
vs
BSX
Boston Scientific Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
AZN
No earnings history for AZN.
BSX
2 of 4
at or beyond implied
Report
implied
realized
× implied
Oct 28 '26
±6.8%
▼
−5.84%
×0.85
Q2 FY26
±8.4%
▼
−0.04%
×0.00
Q1 FY26
±5.2%
▲
+8.99%
×1.73
Feb 4 '26
±4.5%
▼
−17.59%
×3.91
= implied
AZN realized, solid
BSX realized, hatched
One scale, both sides: full bar = 18%
× = |realized| ÷ implied
Source: market data
AZN
Astrazeneca PLC
Change
186.63
▲
+7.01%
· post 186.35
Mkt cap
$289.5B
Revenue
—
Revenue
—
BSX
Boston Scientific Corp
Change
41.97
▼
−1.69%
· post 42.00
Closed
Oct 30 '26
Mkt cap
$60.8B
Revenue
$5.4B
Q2 FY26
Revenue
$20.1B
FY25
vs
Compare
Closed
Oct 30 '26
AZN
Astrazeneca PLC
vs
BSX
Boston Scientific Corp
186.63
▲
+7.01%
post 186.35
Price
41.97
▼
−1.69%
post 42.00
$289.5B
Mkt cap
$60.8B
—
Revenue
$5.4B
Q2 FY26
—
Revenue
$20.1B
FY25
Change
Change
AZN
186.63
▲
+7.01%
vs
BSX
41.97
▼
−1.69%
Closed
Oct 30 '26